These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1964156)

  • 1. Bactericidal activity of vancomycin, daptomycin, ampicillin and aminoglycosides against vancomycin-resistant Enterococcus faecium.
    Bingen E; Lambert-Zechovsky N; Leclercq R; Doit C; Mariani-Kurkdjian P
    J Antimicrob Chemother; 1990 Nov; 26(5):619-26. PubMed ID: 1964156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bactericidal activity of daptomycin and vancomycin alone or in combination with tobramycin, netilmicin or ampicillin against enterococcus].
    Duez JM; Péchinot A; Siébor E; Cordin X; Kazmierczak A
    Pathol Biol (Paris); 1989 Apr; 37(4):263-8. PubMed ID: 2543946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bactericidal activity of ampicillin, daptomycin, and vancomycin against ampicillin-resistant Enterococcus faecium.
    el-Mady A; Mortensen JE
    Diagn Microbiol Infect Dis; 1991; 14(2):141-5. PubMed ID: 1651825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium.
    Mobarakai N; Quale JM; Landman D
    Antimicrob Agents Chemother; 1994 Feb; 38(2):385-7. PubMed ID: 8192473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal activity of daptomycin against vancomycin-resistant Enterococcus faecium in an in vitro pharmacokinetic model.
    Bingen E; Doit C; Lambert-Zechovsky N; Tod M; Petitjean O; Bourgeois F; Mariani-Kurkdjian P
    Eur J Clin Microbiol Infect Dis; 1991 Dec; 10(12):1062-5. PubMed ID: 1666362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.
    Sakoulas G; Bayer AS; Pogliano J; Tsuji BT; Yang SJ; Mishra NN; Nizet V; Yeaman MR; Moise PA
    Antimicrob Agents Chemother; 2012 Feb; 56(2):838-44. PubMed ID: 22123698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
    Louie A; Baltch AL; Ritz WJ; Smith RP; Asperilla M
    Chemotherapy; 1993; 39(5):302-9. PubMed ID: 8396526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
    J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2")-Id gene.
    Kak V; You I; Zervos MJ; Kariyama R; Kumon H; Chow JW
    Diagn Microbiol Infect Dis; 2000 Aug; 37(4):297-9. PubMed ID: 10974585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococci.
    Cercenado E; Eliopoulos GM; Wennersten CB; Moellering RC
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2201-3. PubMed ID: 1444300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 May; 59(5):2842-8. PubMed ID: 25753639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.
    Machka K; Braveny I
    Eur J Clin Microbiol; 1987 Feb; 6(1):96-9. PubMed ID: 3032613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci.
    Harwick HJ; Kalmanson GM; Guze LB
    Antimicrob Agents Chemother; 1973 Oct; 4(4):383-7. PubMed ID: 4791300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci.
    Verbist L
    Antimicrob Agents Chemother; 1987 Feb; 31(2):340-2. PubMed ID: 3032099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections.
    Wagenlehner FM; Lehn N; Witte W; Naber KG
    Chemotherapy; 2005 May; 51(2-3):64-9. PubMed ID: 15870498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studies.
    Stratton CW; Weeks LS
    Diagn Microbiol Infect Dis; 1990; 13(3):245-52. PubMed ID: 2166634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
    Vouillamoz J; Moreillon P; Giddey M; Entenza JM
    J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci.
    Rand KH; Houck H
    J Antimicrob Chemother; 2004 Mar; 53(3):530-2. PubMed ID: 14963062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.